|4Apr 18, 8:00 AM ET

Fisher Alan 4

4 · Neuphoria Therapeutics Inc. · Filed Apr 18, 2025

Insider Transaction Report

Form 4
Period: 2025-04-16
Fisher Alan
Director
Transactions
  • Award

    Restricted Stock Units

    2025-04-16+13,56613,658 total
    Common Stock (13,566 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
  • [F2]Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT